Global SERD Therapeutics Market to Reach $4.0 Billion by 2030
Market Report Coverage - SERD Therapeutics
Market Segmentation
• By Product – Faslodex, RAD1901, GDC-9545, AZD9833, SAR439859, Other Generics
• By Application – First-line treatment and second-line treatment
Regional Segmentation
• North America – U.S., Canada
• Europe – Germany, France, U.K., Italy, Spain, and Rest-of-Europe
• Asia-Pacific – China, Japan, and Rest-of-Asia-Pacific (RoAPAC)
• Rest-of-the-World
Growth Drivers
• Rising incidence of breast cancer
• Advanced route of administration: oral drug delivery
Market Challenges
• Resistance to endocrine therapy
Market Opportunities
• SERDs as combination therapy
• Therapeutic potential in different types of cancer
Key Companies Profiled
AstraZeneca, Plc, Novartis AG, Sanofi S.A, Hofmann-la Roche AG, G1 Therapeutics, Zentalis Pharmaceuticals, Zenopharm LLC, Radius Health, Eli Lilly and Company, Teva Pharmaceuticals Industries Ltd, InventisBio, Dr. Reddy’s Laboratories, Glenmark Pharmaceuticals, HBT Labs, and Amneal pharmaceuticals, Inc.
Key Questions Answered in this Report:
• What is SERD therapy?
• How did the SERD therapy market evolve, and what is its scope in the future?
• What are the major market drivers, restraints, and opportunities in the global SERD therapeutics market?
• What are the key developmental strategies that are being implemented by the key players to sustain this market?
• What is the impact of generics on branded therapy?
• What is the impact of COVID-19 on this market?
• What are the guidelines implemented by different government bodies to regulate the approval of products to be used in breast cancer treatment?
• How is SERD therapy being utilized for the treatment of postmenopausal women with breast cancer?
• What was the market size of the leading segments and sub-segments of the global SERD therapeutics market in 2019?
• How will the industry evolve during the forecast period 2020-2030?
• What will be the growth rate of the SERD therapeutics market during the forecast period?
• How will each segment of the global SERD therapeutics market grow during the forecast period, and what will be the revenue generated by each segment by the end of 2030?
• Which product segment and application segment are expected to register the highest CAGR for the global SERD therapeutics market?
• What is the market size of the SERD therapeutics market in different countries of the world?
• Which geographical region is expected to contribute to the highest sales in the global SERD therapeutics market?
• What is the regulatory framework for the SERD therapeutics market in different regions?
• What are the key strategies incorporated by the players of the global SERD therapeutics market to sustain the competition and retain their supremacy?
Market Overview
The unmet clinical benefits and quest for novel therapies with better efficacy and safety to improve the quality of life in patients living with breast cancer treatment, complete estrogen receptor inhibition, and resistance to multiple endocrine therapies led to the discovery of SERD therapies.SERD therapy has been extensively accepted and used as both monotherapy and in combination with other therapeutic agents.
The potential of SERD therapy in breast cancer treatment is yet to be fully discovered, thus leaving a substantial scope of innovation and research in the field.
The global SERD therapeutics market was valued at $1000.2 million in 2019 and is expected to reach $4085.0 million by 2030, witnessing a CAGR of 16.66% during the forecast period 2020-2030. The market growth can mainly be attributed to the increasing breast cancer incidence and mortality worldwide, increasing number of relapsed or refractory cases in breast cancer, unmet clinical benefits with existing breast cancer treatments targeting hormone receptor-positive metastatic breast cancer, eased route of administration and dosage exposure, rising focus of the key players on research and development (R&D) activity for new product launch, and increased government and private funding for improved safety and outcomes provided by SERD therapy.
The global SERD therapeutics market is expected to witness high growth in the future. The increasing global breast cancer incidence and mortality and increased demand for endocrine therapies that cure chronic conditions completely and improve the quality of life of patients are the major factors anticipated to contribute to the growth of the global SERD therapeutics market.
Furthermore, the increasing number of relapsed or refractory cases in breast cancer, unmet clinical benefits with existing breast cancer treatments targeting hormone receptor-positive metastatic breast cancer, painful route of administration and limited dosage exposure will augment the SERD therapeutics market.Also, the increased use of SERDs as combination therapy with other endocrine agents and rising focus of the key players on research and development (R&D) activity for new product launch is expected to drive the market.
Rise in government and private funding for improved safety and outcomes provided by SERD therapy are additional factors propelling the growth.
Within the research report, the market is segmented based on therapy type, product, region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.
Competitive Landscape
The global SERD therapeutics market is currently dominated by Sandoz, Mylan N.V., Glenmark Pharmaceuticals, Dr. Reddy’s Laboratories, Accord Healthcare, and Teva Pharmaceuticals Industries Ltd. The market dominance of these companies can be attributed to cost-effective generic fulvestrant availability in the market. As of 2018, AstraZeneca Plc was the only company to offer SERD therapy in the global SERD therapeutics market. The company has now witnessed a sharp decline after generic launch in several regions. With the pipeline of SERD therapeutics, the market is expected to augment tremendously. Some of the major companies with strong and early pipeline include Sanofi S.A., Hoffmann-La Roche AG, Radius Health, and AstraZeneca Plc.
Based on region, North America is the leading contributor to the SERD therapeutics market in terms of revenue.The growing breast cancer incidence, relapse from existing endocrine therapies, and the substantial research and development made in the field are consequentially promoting the growth of the North America SERD therapeutics market.
Also, the Asia-Pacific and Europe regions are expected to register the high CAGR during the forecast period of 2020-2030.
Countries Covered
• North America
• U.S.
• Canada
• Europe
• Germany
• Italy
• France
• Spain
• U.K.
• Rest-of-Europe
• Asia-Pacific
• China
• Japan
• Rest-of-Asia-Pacific
• Rest-of-World
Global SERD Therapeutics Market
Migraine Drugs Market Therapeutics in Healthcare organizations are operating in a dynamic set-up, wherein they are required to incorporate unprecedented advances in diagnostic and therapeutic procedures, every now and then.
It has thus become an uphill task for organizations to reap benefits from the latest and upcoming information technologies and offer discerning managed care to patients.Top Market Driving Key Vendors of Global Migraine Drugs Market Therapeutics are, Wave Life Sciences Ltd., Copernicus Therapeutics Inc., Imugene, Caperna, Phylogica, Protagonist Therapeutics, Benitec Biopharma, EGEN (Expression Genetics), Benitec Biopharma, BioMedica (Oxford BioMedica), Transgeneand others.The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market.
The report provides detailed information and strategies of the key players in the industry.
The report also gives a broad study of the different market segments and regions.We offer solutions to make this transformation a smooth-sail for companies, irrespective of their size.
Our research zeroes in on patient expectations and offers ground-breaking solutions to address the same.Table of Content:1 Report Overview 2 Global Growth Trends 3 Market Share by Key Players 4 Breakdown Data by Type and Application 5 United States 6 Europe 7 China 8 Japan 9 Southeast Asia 10 India 11 Central & South America 12 International Players Profiles 13 Market Forecast 2019-2025 14 Analyst’s Viewpoints/Conclusions15 Appendix Thanks to the extraordinary internet penetration, patients have been rendered more conscientious.
Consequently, the demand for sophisticated, transparent, and personalized healthcare services has skyrocketed.
The Global Myocardial Infarction Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.
The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved.
The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.The report classifies the market into different segments based on product and distribution channel.
These segments are studied in detail incorporating the market estimates and forecasts at regional and country level.
The segment analysis is useful in understanding the growth areas and probable opportunities of the market.Leading Segment in this market:By Product – AnalgesicsBy Geography – North America (NA)Final Report will cover the impact of COVID-19 on this industry.Browse the complete Global Myocardial Infarction Therapeutics Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 @ https://www.decisiondatabases.com/ip/9253-myocardial-infarction-therapeutics-market-reportThe report also covers the complete competitive landscape of the global Myocardial Infarction Therapeutics market with company profiles of key players such as:Novartis N.V.Daiichi Sankyo Company LimitedBristol-Myers Squibb CompanyBoehringer Ingelheim GmbHAstraZenecaApotex Inc.SandozPar Pharmaceutical Companies, Inc.Mylan N.V.Pfizer Inc.A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.SEGMENTATIONS IN THE REPORT:By Product:AnalgesicsAntiplatelet AgentsVasodilatorsThrombolytics and Anti-Thrombotic AgentsGlycoprotein Iib/Iiia InhibitorsΒ Adrenergic BlockersAngiotensin Receptor AntagonistsAngiotensin Converting Enzyme InhibitorsBy Distribution Channel:HospitalsHospital PharmaciesDrug StoresOnline Drug StoresBy Geography:North America (NA)Europe (EU)Asia Pacific (APAC)Latin America (LA)Middle East & Africa (MEA)Download Free Sample Report of Global Myocardial Infarction Therapeutics Market @ https://www.decisiondatabases.com/contact/download-sample-9253The Global Myocardial Infarction Therapeutics Market has been exhibited in detail in the following chapters –Chapter 1 Myocardial Infarction Therapeutics Market PrefaceChapter 2 Executive SummaryChapter 3 Myocardial Infarction Therapeutics Industry AnalysisChapter 4 Myocardial Infarction Therapeutics Market Value Chain AnalysisChapter 5 Myocardial Infarction Therapeutics Market Analysis By ProductChapter 6 Myocardial Infarction Therapeutics Market Analysis By Distribution ChannelChapter 7 Myocardial Infarction Therapeutics Market Analysis By GeographyChapter 8 Competitive Landscape Of Myocardial Infarction Therapeutics CompaniesChapter 9 Company Profiles Of Myocardial Infarction Therapeutics IndustryPurchase the complete Global Myocardial Infarction Therapeutics Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-9253Other Reports by DecisionDatabases.com:Global Pruritus Therapeutics Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Gastroesophageal Reflux Disease Therapeutics Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
Migraine Drugs Market Therapeutics in Healthcare organizations are operating in a dynamic set-up, wherein they are required to incorporate unprecedented advances in diagnostic and therapeutic procedures, every now and then.
It has thus become an uphill task for organizations to reap benefits from the latest and upcoming information technologies and offer discerning managed care to patients.Top Market Driving Key Vendors of Global Migraine Drugs Market Therapeutics are, Wave Life Sciences Ltd., Copernicus Therapeutics Inc., Imugene, Caperna, Phylogica, Protagonist Therapeutics, Benitec Biopharma, EGEN (Expression Genetics), Benitec Biopharma, BioMedica (Oxford BioMedica), Transgeneand others.The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market.
The report provides detailed information and strategies of the key players in the industry.
The report also gives a broad study of the different market segments and regions.We offer solutions to make this transformation a smooth-sail for companies, irrespective of their size.
Our research zeroes in on patient expectations and offers ground-breaking solutions to address the same.Table of Content:1 Report Overview 2 Global Growth Trends 3 Market Share by Key Players 4 Breakdown Data by Type and Application 5 United States 6 Europe 7 China 8 Japan 9 Southeast Asia 10 India 11 Central & South America 12 International Players Profiles 13 Market Forecast 2019-2025 14 Analyst’s Viewpoints/Conclusions15 Appendix Thanks to the extraordinary internet penetration, patients have been rendered more conscientious.
Consequently, the demand for sophisticated, transparent, and personalized healthcare services has skyrocketed.
The Global Myocardial Infarction Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.
The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved.
The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.The report classifies the market into different segments based on product and distribution channel.
These segments are studied in detail incorporating the market estimates and forecasts at regional and country level.
The segment analysis is useful in understanding the growth areas and probable opportunities of the market.Leading Segment in this market:By Product – AnalgesicsBy Geography – North America (NA)Final Report will cover the impact of COVID-19 on this industry.Browse the complete Global Myocardial Infarction Therapeutics Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 @ https://www.decisiondatabases.com/ip/9253-myocardial-infarction-therapeutics-market-reportThe report also covers the complete competitive landscape of the global Myocardial Infarction Therapeutics market with company profiles of key players such as:Novartis N.V.Daiichi Sankyo Company LimitedBristol-Myers Squibb CompanyBoehringer Ingelheim GmbHAstraZenecaApotex Inc.SandozPar Pharmaceutical Companies, Inc.Mylan N.V.Pfizer Inc.A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.SEGMENTATIONS IN THE REPORT:By Product:AnalgesicsAntiplatelet AgentsVasodilatorsThrombolytics and Anti-Thrombotic AgentsGlycoprotein Iib/Iiia InhibitorsΒ Adrenergic BlockersAngiotensin Receptor AntagonistsAngiotensin Converting Enzyme InhibitorsBy Distribution Channel:HospitalsHospital PharmaciesDrug StoresOnline Drug StoresBy Geography:North America (NA)Europe (EU)Asia Pacific (APAC)Latin America (LA)Middle East & Africa (MEA)Download Free Sample Report of Global Myocardial Infarction Therapeutics Market @ https://www.decisiondatabases.com/contact/download-sample-9253The Global Myocardial Infarction Therapeutics Market has been exhibited in detail in the following chapters –Chapter 1 Myocardial Infarction Therapeutics Market PrefaceChapter 2 Executive SummaryChapter 3 Myocardial Infarction Therapeutics Industry AnalysisChapter 4 Myocardial Infarction Therapeutics Market Value Chain AnalysisChapter 5 Myocardial Infarction Therapeutics Market Analysis By ProductChapter 6 Myocardial Infarction Therapeutics Market Analysis By Distribution ChannelChapter 7 Myocardial Infarction Therapeutics Market Analysis By GeographyChapter 8 Competitive Landscape Of Myocardial Infarction Therapeutics CompaniesChapter 9 Company Profiles Of Myocardial Infarction Therapeutics IndustryPurchase the complete Global Myocardial Infarction Therapeutics Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-9253Other Reports by DecisionDatabases.com:Global Pruritus Therapeutics Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Gastroesophageal Reflux Disease Therapeutics Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.